Andrew Witty
Sir Andrew Witty is a British business executive who currently serves as the chief executive officer (CEO) ofUnitedHealth Group, a leading healthcare company, since February 2021. In this role, Witty is responsible for setting the strategic direction and overseeing the overall performance of the organization, as well as driving its long-term growth agenda. He is alsoa member of the UnitedHealth Group Board of Directors.
Prior to joining UnitedHealth Group, Witty held various leadership positions atGlaxoSmithKline plc (GSK), a prominent pharmaceutical manufacturer, from 1985 to 2017.He served as the CEO and a director of GSK from 2008 to 2017, during which he played a pivotal role in shaping the company's operations and growth. Before assuming the CEO position, Witty served as the president of GSK Europe.
Beyond his corporate roles, Witty has been actively involved in academia and public service. He served asthe chancellor of the University of Nottingham, a renowned British public research university. Witty is alsoa member of the Singapore Prime Minister’s Research, Innovation and Enterprise Council, contributing his expertise to drive research and innovation in the country. In addition, he assumed the role ofchair for the Imperial College Business School Advisory Boardin November 2020.
In recognition of his significant contributions to the U.K. economy,Witty was knighted in 2012. He has also been honoured as anhonorary citizen of Singapore in 2017, acknowledging his contributions to the country's growth and development. Witty holds honorary degrees from prestigious institutions including Exeter, Manchester, and Nottingham Universities.
During the COVID-19 pandemic, Witty demonstrated his commitment to global health by taking an unpaid leave as aspecial envoy at the World Health Organization (WHO)from April to December 2020. In this role, he co-led efforts to accelerate responses to the pandemic and played a crucial role in advancing global healthcare initiatives.
With his extensive experience in the pharmaceutical and healthcare sectors, along with his dedication to public service and academia, Sir Andrew Witty has established himself as a respected leader in the industry.
